Cailin Conner

DocwireNews

According to a scoping review in the <a href="https://www.japha.org/article/S1544-3191(23)00251-0/fulltext#%20" target="_blank" rel="noopener">Journal of the American Pharmacists Association</a>, &ldquo;There is lack of strong evidence to support pharmacist-driven CGM [continuous glucose monitoring] in the community pharmacy setting. However, small studies suggest pharmacist-driven CGM is feasible and beneficial in the ambulatory care setting.&rdquo;A team of investigators from the Pharmacotherapeutics &amp; Clinical Research Department at the University of South Florida sought to identify opportunities and barriers to implementing pharmacist-driven CGM services in community and ambulatory care settings, as well as examine the clinical outcomes resulting from pharmacist-driven CGM.To compile a comprehensive understanding of the subject, a health librarian conducted an extensive search of several reputable databases, including Ovid MEDLINE, Cochrane CENTRAL, Embase, Web of Science, Scopus, and International Pharmaceutical Abstracts.From an initial pool of 942 citations, 249 underwent abstract screening, with 11 ultimately selected for inclusion in the scoping review. These studies presented a varied landscape, with retrospective designs, diverse patient populations, inconsistent control groups, predominantly short-term follow-ups, and small sample sizes. Only 1 of the included studies evaluated pharmacist-driven CGM in a community pharmacy setting, while the remaining 10 were conducted in ambulatory care settings.Barriers to implementing pharmacist-driven CGM services included educational, logistical, workflow, and financial challenges. The need for comprehensive training, logistical considerations related to device management, workflow modifications to accommodate CGM services, and financial incentives to motivate pharmacists all presented considerable challenges.However, the reviewed studies consistently reported beneficial outcomes resulting from pharmacist-driven CGM services. These included improvements in the quality of life for individuals with diabetes, increased empowerment through better self-management, and enhanced glycemic control.&ldquo;There is lack of strong evidence to support pharmacist-driven CGM in the community pharmacy setting. However, small studies suggest pharmacist-driven CGM is feasible and beneficial in the ambulatory care setting,&rdquo; the investigators wrote in conclusion. &ldquo;Further exploration of how educational, logistical, workflow, and financial barriers can be overcome is warranted, given potential for improved clinical outcomes.&rdquo;&nbsp;

Roger Rodby, MD

Joel M. Topf, MD, FACP

Seldin Award Winner Advocates Online Education

NKF Spring Clinical Meetings 2025

Hatem Soliman, MD

The Future of Dendritic Cell Vaccines in HER2+ Breast Cancer: Toward De-Escalation of Chemotherapy

HER2 Breast Cancer

Jordana Jampel

Mechanism of Positive Association Between Parkinson’s Disease and Melanoma Revealed in New Research

Melanoma

Latest News

Scoping Review Identifies Opportunities and Barriers to Implementing Pharmacist-Driven CGM Services

Diabetes

Smaller-scale studies indicate the feasibility and advantages of pharmacist-driven CGM in ambulatory care settings.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe